Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure

被引:33
作者
Tsutamoto, Takayoshi [1 ]
Sakai, Hiroshi [1 ]
Tanaka, Toshinari [1 ]
Fujii, Masanori [1 ]
Yamamoto, Takashi [1 ]
Wada, Atsuyuki [1 ]
Ohnishi, Masato [1 ]
Horie, Minoru [1 ]
机构
[1] Shiga Univ Med Sci, Otsu, Shiga 5202192, Japan
关键词
active renin concentration; angiotensin II; brain natriuretic peptide; heart failure; prognosis;
D O I
10.1253/circj.71.915
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Plasma renin activity (PRA) may be limited to angiotensinogen levels, which decrease in patients with heart failure (HF) because of liver congestion. Methods and Results To evaluate whether the plasma active renin concentration (ARC) is a more useful prognostic predictor than PRA, the plasma levels of ARC, PRA, angiotensin II, aldosterone, brain natriuretic peptide (BNP), norepinephrine, and hemodynamic parameters were measured in 214 consecutive HF patients who were already taking angiotensin-converting enzyme inhibitors (ACEI) or angiotensin-receptor blockers (ARB). Median follow-up period was 1, 197 days. Of the clinical variables, including pulmonary capillary wedge pressure, right atrial pressure, left ventricular ejection fraction, and neurohumoral factors, only high plasma levels of log ARC (p<0.0001) and log BNP (p=0.0009), but not log PRA, were significant independent prognostic predictors. Log ARC/PRA ratio was significantly higher in nonsurvivors than in survivors. Log ARC/PRA significantly correlated with pulmonary capillary wedge pressure (r=0.305, p<0.0001), right atrial pressure (r=0.222, p=0.001 1), and log BNP (r=0.242, p=0.0004). Conclusions Plasma ARC is superior to PRA and a high plasma ARC is an independent prognostic predictor in HF patients who are already receiving ACEI or ARB.
引用
收藏
页码:915 / 921
页数:7
相关论文
共 36 条
[1]   Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) [J].
Anand, IS ;
Fisher, LD ;
Chiang, YT ;
Latini, R ;
Masson, S ;
Maggioni, AP ;
Glazer, RD ;
Tognoni, G ;
Cohn, JN .
CIRCULATION, 2003, 107 (09) :1278-1283
[2]   LOW ANGIOTENSINOGEN LEVELS ARE RELATED TO THE SEVERITY AND LIVER DYSFUNCTION OF CONGESTIVE-HEART-FAILURE - IMPLICATIONS FOR RENIN MEASUREMENTS [J].
ARNAL, JF ;
CUDEK, P ;
PLOUIN, PF ;
GUYENNE, TT ;
MICHEL, JB ;
CORVOL, P .
AMERICAN JOURNAL OF MEDICINE, 1991, 90 (01) :17-22
[3]   Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction [J].
Benedict, CR ;
Shelton, B ;
Johnstone, DE ;
Francis, G ;
Greenberg, B ;
Konstam, M ;
Probstfield, JL ;
Yusuf, S .
CIRCULATION, 1996, 94 (04) :690-697
[4]   RELATION OF NEUROHUMORAL ACTIVATION TO CLINICAL-VARIABLES AND DEGREE OF VENTRICULAR DYSFUNCTION - A REPORT FROM THE REGISTRY OF STUDIES OF LEFT-VENTRICULAR DYSFUNCTION [J].
BENEDICT, CR ;
JOHNSTONE, DE ;
WEINER, DH ;
BOURASSA, MG ;
BITTNER, V ;
KAY, R ;
KIRLIN, P ;
GREENBERG, B ;
KOHN, RM ;
NICKLAS, JM ;
MCINTYRE, K ;
QUINONES, MA ;
YUSUF, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (06) :1410-1420
[5]   Physiological relevance of renin/prorenin binding and uptake [J].
Catanzaro, Daniel F. .
HYPERTENSION RESEARCH, 2005, 28 (02) :97-105
[6]   A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].
Cohn, JN ;
Tognoni, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675
[7]   Renin, prorenin and the putative (pro)renin receptor [J].
Danser, AHJ ;
Deinum, J .
HYPERTENSION, 2005, 46 (05) :1069-1076
[8]  
Danser AHJ, 1997, CIRCULATION, V96, P220
[9]  
FRANCIS GS, 1993, CIRCULATION, V87, P40
[10]   HEMODYNAMIC AND NEUROHORMONAL EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST LOSARTAN IN PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
GOTTLIEB, SS ;
DICKSTEIN, K ;
FLECK, E ;
KOSTIS, J ;
LEVINE, TB ;
LEJEMTEL, T ;
DEKOCK, M .
CIRCULATION, 1993, 88 (04) :1602-1609